The Broad Reach Of New 'Failure-To-Warn-FDA' Claims
Recently, the Ninth Circuit created a new state-law cause of action against medical device manufacturers: "failure to warn the U.S. Food and Drug Administration." The en banc opinion in Stengel v. Medtronic...To view the full article, register now.
Already a subscriber? Click here to view full article